CollPlant Biotechnologies (CLGN) Gross Margin Growth (3y) (2020 - 2026)
CollPlant Biotechnologies (CLGN) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 722.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -191.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -162.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -40.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -35,782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -35,782.00 |
| Dec 31, 2025 | -21,310.00 |
| Sep 30, 2025 | -10,715.00 |
| Jun 30, 2025 | -391.06 Mn |
| Dec 31, 2024 | 1,092.00 |
| Sep 30, 2024 | 142.19 Mn |
| Jun 30, 2024 | -15,318.00 |
| Mar 31, 2024 | -55,001.00 |
| Dec 31, 2023 | -20,961.00 |
| Sep 30, 2023 | -6,526.00 |
| Jun 30, 2023 | 8,485.00 |
| Mar 31, 2023 | 294.00 |
| Dec 31, 2022 | -2,694.00 |
| Sep 30, 2022 | -14,721.00 |
| Jun 30, 2022 | 1,125.00 |
| Dec 31, 2021 | -16,785.00 |
| Sep 30, 2021 | -142.86 Mn |
| Jun 30, 2021 | -2,527.00 |
| Mar 31, 2021 | 500.00 |
| Dec 31, 2020 | -4,346.00 |